Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Ingelman-Sundberg

Showing results (141-150 of 263) with videos related to

Pageof 27
Sort By:
Human Mutation|May 13, 2008
Mutations in CYP1B1 cause primary congenital glaucoma by reduction of either activity or abundance of the enzymeGabriela Chavarria-Soley, Heinrich Sticht, Eleni Aklillu, et al.
Molecular Pharmacology|August 16, 2003
Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1Eleni Aklillu, Juan Antonio Carrillo, Eyasu Makonnen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 26, 2019
Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patientsLine S Bråten, Tore Haslemo, Marin M Jukic, et al.
Life Sciences|March 9, 2010
The transcription factor GATA-4 regulates cytochrome P4502C19 gene expressionJessica Mwinyi, Yvonne Hofmann, Rasmus Steen Pedersen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2004
Cytochrome P450 1B1 gene polymorphisms and postmenopausal endometrial cancer riskTove Rylander-Rudqvist, Sara Wedrén, Gudrun Jonasdottir, et al.
JAMA Network Open|August 8, 2024
Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs: A Systematic Review and Meta-AnalysisFilip Milosavljevic, Marina Manojlovic, Lena Matkovic, et al.
Pharmacogenetics|July 13, 2004
Polymorphic NF-Y dependent regulation of human nicotine C-oxidase (CYP2A6)Oliver von Richter, Marià Pitarque, Cristina Rodríguez-Antona, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 21, 2017
Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokineticsMaría Santos, Mikko Niemi, Masahiro Hiratsuka, et al.
Clinical Pharmacology and Therapeutics|November 15, 2017
The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature DatabaseAndrea Gaedigk, Magnus Ingelman-Sundberg, Neil A Miller, et al.
Clinical Pharmacology and Therapeutics|January 18, 2006
A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressantsSarah C Sim, Carl Risinger, Marja-Liisa Dahl, et al.
Pageof 27

Showing results (141-150 of 263) with videos related to

Sort By:
Pageof 27
Human Mutation|May 13, 2008
Mutations in CYP1B1 cause primary congenital glaucoma by reduction of either activity or abundance of the enzymeGabriela Chavarria-Soley, Heinrich Sticht, Eleni Aklillu, et al.
Molecular Pharmacology|August 16, 2003
Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1Eleni Aklillu, Juan Antonio Carrillo, Eyasu Makonnen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 26, 2019
Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patientsLine S Bråten, Tore Haslemo, Marin M Jukic, et al.
Life Sciences|March 9, 2010
The transcription factor GATA-4 regulates cytochrome P4502C19 gene expressionJessica Mwinyi, Yvonne Hofmann, Rasmus Steen Pedersen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2004
Cytochrome P450 1B1 gene polymorphisms and postmenopausal endometrial cancer riskTove Rylander-Rudqvist, Sara Wedrén, Gudrun Jonasdottir, et al.
JAMA Network Open|August 8, 2024
Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs: A Systematic Review and Meta-AnalysisFilip Milosavljevic, Marina Manojlovic, Lena Matkovic, et al.
Pharmacogenetics|July 13, 2004
Polymorphic NF-Y dependent regulation of human nicotine C-oxidase (CYP2A6)Oliver von Richter, Marià Pitarque, Cristina Rodríguez-Antona, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 21, 2017
Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokineticsMaría Santos, Mikko Niemi, Masahiro Hiratsuka, et al.
Clinical Pharmacology and Therapeutics|November 15, 2017
The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature DatabaseAndrea Gaedigk, Magnus Ingelman-Sundberg, Neil A Miller, et al.
Clinical Pharmacology and Therapeutics|January 18, 2006
A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressantsSarah C Sim, Carl Risinger, Marja-Liisa Dahl, et al.
Pageof 27